Deficits in human trisomy 21 iPSCs and neurons

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 24, 2013, Pages 9962-9967

  Weick, Jason P ^a,c   Held, Dustie L ^a   Bonadurer III, George F ^a   Doers, Matthew E ^a   Liu, Yan ^a   Maguire, Chelsie ^a   Clark, Aaron ^a   Knackert, Joshua A ^a   Molinarolo, Katharine ^a   Musser, Michael ^a   Yao, Lin ^a   Yin, Yingnan ^a   Lu, Jianfeng ^a   Zhang, Xiaoqing ^a   Zhang, Su Chun ^a,b   Bhattacharyya, Anita ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Developmental disorders

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISOMY; FIBROBLAST; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NERVE CELL; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE; TRISOMY 21;

CEREBRAL CORTEX; DEVELOPMENTAL DISORDERS;

CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; FIBROBLASTS; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDUCED PLURIPOTENT STEM CELLS; MOSAICISM; NEURONS; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNAPTIC POTENTIALS;

EID: 84878977690     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216575110     Document Type: Article

References (61)

1. Parker SE, et al. (2010) Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88(12):1008-1016.
2. Lejeune J, Turpin R, Gautier M (1959) Le mongolisme, premier exemple d'aberration autosomique humaine. Annals of Genetics 1(2):41-49.
3. Gardiner K, Davisson M (2000) The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol 1(2):REVIEWS0002.
4. Sturgeon X, Gardiner KJ (2011) Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm Genome 22(5-6):261-271.
5. Letourneau A, Antonarakis SE (2012) Genomic determinants in the phenotypic variability of Down syndrome. Prog Brain Res 197(2012):15-28.
6. Takahashi K, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872. (Pubitemid 350138099)
7. Devlin L, Morrison PJ (2004) Mosaic Down's syndrome prevalence in a complete population study. Arch Dis Child 89(12):1177-1178. (Pubitemid 39574044)
8. Maclean GA, et al. (2012) Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci USA 109(43):17567-17572.
9. Bock C, et al. (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3):439-452.
10. Guenther MG, et al. (2010) Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2):249-257.
11. Hu BY, et al. (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 107(9):4335-4340.
12. Seki T, et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7(1):11-14.
13. Luong MX, et al. (2011) A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell 8(4):357-359.
14. Boulting GL, et al. (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29(3):279-286.
15. Mayshar Y, et al. (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7(4):521-531.
16. Zhang X, et al. (2010) Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 7(1):90-100.
17. Reeves RH, Baxter LL, Richtsmeier JT (2001) Too much of a good thing: Mechanisms of gene action in Down syndrome. Trends Genet 17(2):83-88. (Pubitemid 32140787)
18. Gardiner K, et al. (2010) Down syndrome: From understanding the neurobiology to therapy. J Neurosci 30(45):14943-14945.
19. Epstein CJ (1990) The consequences of chromosome imbalance. Am J Med Genet Suppl 7(1990):31-37.
20. Antonarakis SE (2001) Chromosome 21: From sequence to applications. Curr Opin Genet Dev 11(3):241-246.
21. Biancotti JC, et al. (2010) Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 28(9):1530-1540.
22. Hui CC, Angers S (2011) Gli proteins in development and disease. Annu Rev Cell Dev Biol 27:513-537.
23. Wisniewski KE, Laure-Kamionowska M, Wisniewski HM (1984) Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome. N Engl J Med 311(18):1187-1188. (Pubitemid 14012592)
24. Ross MH, Galaburda AM, Kemper TL (1984) Down's syndrome: Is there a decreased population of neurons? Neurology 34(7):909-916. (Pubitemid 14076456)
25. Larsen KB, et al. (2008) Reduced cell number in the neocortical part of the human fetal brain in Down syndrome. Ann Anat 190(5):421-427.
26. Golden JA, Hyman BT (1994) Development of the superior temporal neocortex is anomalous in trisomy 21. J Neuropathol Exp Neurol 53(5):513-520. (Pubitemid 24276810)
27. Li XJ, et al. (2009) Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 136(23):4055-4063.
28. Pankratz MT, et al. (2007) Directed Neural Differentiation of hESCs via an Obligated Primitive Anterior Stage. Stem Cells 25(6):1511-1520. (Pubitemid 47106020)
29. Wisniewski KE (1990) Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 7(1990):274-281.
30. Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA (1990) Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9(4):181-190. (Pubitemid 20287898)
31. Haydar TF, Nowakowski RS, Yarowsky PJ, Krueger BK (2000) Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse. J Neurosci 20(11):4156-4164. (Pubitemid 30365686)
32. Colon EJ (1972) The structure of the cerebral cortex in Down's Syndrome: A quantitative analysis. Neuropädiatrie 3(4):362-376.
33. Chakrabarti L, Galdzicki Z, Haydar TF (2007) Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27(43):11483-11495. (Pubitemid 350006912)
34. Bhattacharyya A, Svendsen CN (2003) Human neural stem cells: A new tool for studying cortical development in Down's syndrome. Genes Brain Behav 2(3):179-186. (Pubitemid 36898804)
35. Bhattacharyya A, McMillan E, Chen SI, Wallace K, Svendsen CN (2009) A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. Dev Neurosci 31(6):497-510.
36. Helguera P, et al. (2005) ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J Neurosci 25(9):2295-2303. (Pubitemid 40322270)
37. Busciglio J, et al. (2002) Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33(5):677-688. (Pubitemid 34219240)
38. Helguera P, et al. (2013) Adaptive downregulation of mitochondrial function in down syndrome. Cell Metab 17(1):132-140.
39. Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC (2007) Synaptic and cognitive abnormalities in mouse models of Down syndrome: Exploring genotype-phenotype relationships. J Comp Neurol 504(4):329-345. (Pubitemid 47437199)
40. Kleschevnikov AM, et al. (2004) Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci 24(37):8153-8160.
41. Wu H, et al. (2007) Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines. Proc Natl Acad Sci USA 104(34):13821-13826. (Pubitemid 350003404)
42. Weick JP, Liu Y, Zhang SC (2011) Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network. Proc Natl Acad Sci USA 108(50):20189-20194.
43. Fernandez F, Garner CC (2007) Over-inhibition: A model for developmental intellectual disability. Trends Neurosci 30(10):497-503. (Pubitemid 47513234)
44. Chakrabarti L, et al. (2010) Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci 13(8):927-934.
45. Wang Y, Floor E (1998) Hydrogen peroxide inhibits the vacuolar H+-ATPase in brain synaptic vesicles at micromolar concentrations. J Neurochem 70(2):646-652. (Pubitemid 28079353)
46. Chen BT, Avshalumov MV, Rice ME (2001) H(2)O(2) is a novel, endogenous modulator of synaptic dopamine release. J Neurophysiol 85(6):2468-2476. (Pubitemid 32525525)
47. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down 's syndrome neurons in vitro. Nature 378(6559):776-779. (Pubitemid 26004408)
48. Esposito G, et al. (2008) Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum Mol Genet 17(3):440-457.
49. Coskun PE, Busciglio J (2012) Oxidative stress and mitochondrial dysfunction in Down's syndrome: Relevance to aging and dementia. Curr Gerontol Geriatr Res 2012(2012):383170.
50. Briggs JA, et al. (2013) Integration-free induced pluripotent stemcellsmodel genetic and neural developmental features of down syndrome etiology. Stem Cells 31(3):467-478.
51. Zigman WB, Lott IT (2007) Alzheimer's disease in Down syndrome: Neurobiology and risk. Ment Retard Dev Disabil Res Rev 13(3):237-246. (Pubitemid 47613278)
52. Zhu X, Lee HG, Perry G, Smith MA (2007) Alzheimer disease, the two-hit hypothesis: An update. Biochim Biophys Acta 1772(4):494-502. (Pubitemid 46400383)
53. Zana M, Janka Z, Kálmán J (2007) Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease. Neurobiol Aging 28(5):648-676. (Pubitemid 46349350)
54. Perluigi M, Butterfield DA (2012) Oxidative stress and Down syndrome: A route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res 2012(2012):724904.
55. Weitzdoerfer R, Dierssen M, Fountoulakis M, Lubec G (2001) Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J Neural Transm Suppl 61(2001):59-70. (Pubitemid 38085072)
56. Takashima S, Becker LE, Armstrong DL, Chan F (1981) Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study. Brain Res 225(1):1-21. (Pubitemid 11026571)
57. Shi Y, et al. (2012) A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med 4(124):124ra29.
58. Yu J, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920.
59. Hu BY, Zhang SC (2010) Directed differentiation of neural-stem cells and subtypespecific neurons from hESCs. Methods Mol Biol 636(2010):123-137.
60. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19(12):1129-1133. (Pubitemid 33115698)
61. Zhang SC (2006) Neural subtype specification from embryonic stem cells. Brain Pathol 16(2):132-142. Stroke, National Institutes of Health Development, National Institutes of Health Development, National Institutes of Health